Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Nano-X Imaging Ltd.NASDAQ: NNOX

EBITDA · Q4 FY2025 · quarter ended Dec 2025

EBITDA remains negative

Q4 FY2025 EBITDA was -$15.04M, compared with -$11.22M a year earlier. Trailing-twelve-month EBITDA was -$49M.

Context

  • EBITDA amounted to 376.3% of revenue in FY2025, down 22.6 pp from a year earlier.
  • EBITDA grew in size in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of -$69.89M (-42.6%) for the fiscal year ending Dec 2026, a slowdown from the -8.9% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
-$15.04M-33.3% QoQ
Last fiscal yearDec 2025
-$49M-8.9% YoY
LTMDec 2025
-$49M-11.0% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-34.0%-0.2%+33.8 pp
1 year-8.9%-42.6%-33.8 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
(49M) USD
Year-over-year change
-8.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's LTM Dec 2025 EBITDA of -$49M is the 6th highest of the 11 companies compared; the peer median is -$50.1M.
  • Its year-over-year change of -11.0% is the 7th highest of 11, against a peer median of +5.6%.
  • EBITDA amounts to 376.3% of revenue for NNOX, versus a peer median of 61.0%.
NNOX Competitors Peer median
EBITDA for NNOX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNWVSANUWAVE Health, Inc.LTM Mar 2026$22.67M +217.1%+59.4%51.1%
INGNInogen, Inc.LTM Mar 2026-$5.23M +26.2%—1.5%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026-$20.95M +5.5%—46.7%
MXCTMaxCyte, Inc.LTM Mar 2026-$34.64M +5.7%—107.3%
PROFProfound Medical Corp.LTM Mar 2026-$37.85M +9.1%—200.6%
NNOXNano-X Imaging Ltd.LTM Dec 2025-$49M -11.0%—376.3%
OMOutset Medical, Inc.LTM Mar 2026-$62.35M +22.0%—53.0%
QTRXQuanterix CorporationLTM Mar 2026-$84.67M -104.0%—58.4%
CATXPerspective Therapeutics, Inc.LTM Mar 2026-$110.64M -31.7%—17902.8%
HSDTSolana CompanyLTM Mar 2026-$135.55M -1012.4%—1413.6%
HCATHealth Catalyst, Inc.LTM Mar 2026-$192.37M -1267.9%—63.6%
Peer median (excluding NNOX) -$50.1M+5.6%+59.4%61.0%

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.3M8.58M9.91M11.28M13.02M
Cost of Revenue2.82M15.46M16.5M21.89M25.81M
Gross Profit(1.51M)(6.88M)(6.59M)(10.61M)(12.79M)
Gross Margin-116.0%-80.2%-66.6%-94.0%-98.2%
Research & Development17.12M26.51M26.05M20.18M19.24M
Selling, General & Admin41.74M45.63M28.39M25.75M27.1M
Operating Expenses60.05M72.33M56M46.14M47.91M
Depreciation & Amortization2.29M11.51M11.81M11.73M11.7M
EBITDA(59.27M)(75.7M)(47.69M)(45.01M)(49M)
EBITDA Margin-4544.9%-882.4%-481.5%-398.9%-376.3%
Operating Income(61.56M)(109.71M)(62.59M)(56.75M)(60.7M)
Operating Margin-4720.7%-1279.0%-631.9%-502.9%-466.2%
Interest Income0789K1.65M2.87M1.42M
Interest Expense288K0000
Other Income / Expenses(288K)(14.67M)1.47M2.87M(16.11M)
Income Before Tax(61.85M)(108.92M)(61.12M)(53.87M)(76.81M)
Pre-Tax Margin-4742.8%-1269.8%-617.0%-477.5%-589.9%
Income Tax Expense(48K)(3.68M)(339K)(358K)(1.79M)
Net Income(61.8M)(105.24M)(60.78M)(53.52M)(75.02M)
Net Margin-4739.1%-1226.9%-613.6%-474.3%-576.1%
EPS (Basic)(1.28)(2.01)(1.08)(0.91)(1.16)
EPS (Diluted)(1.28)(2.01)(1.08)(0.91)(1.16)
Weighted Avg Shares48.22M52.24M56.37M58.62M64.79M
Weighted Avg Shares (Diluted)48.22M52.24M56.37M58.62M64.79M

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.